Frontlight ResearchEarly access
Trial site
Neurokard Sp. z o.o.
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis7 trials
- Migraine2 trials
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Merz Therapeutics GmbH2 trials
- Zenas BioPharma (USA), LLC2 trials
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- Novartis Pharma AG1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis4 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026